AUR Reports Fiscal Q3 Loss
Attributable profit was -7.27亿美元, down 19.18% year over year; basic EPS was -0.37美元.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Attributable profit was -7.27亿美元, down 19.18% year over year; basic EPS was -0.37美元.
On Thursday, Puma Biotechnology (NASDAQ: PBYI ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Puma Biotechnology reported tot
Hain Celestial said it agreed to sell its international business to Aurelius for $323 million and used the call to outline fiscal 2026 results. The company said North America returned to organic sales growth and adjusted EBITDA rose 55% in the fourth quarter.
Signet Jewelers said second-quarter comps rose over 2% and adjusted EPS grew more than 35%, while management raised full-year guidance and highlighted brand and website upgrades.